Zurich Cantonal Bank
ADCT icon

Zurich Cantonal Bank’s ADC Therapeutics ADCT Stock Holding History

Zurich Cantonal Bank’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-21,408
Closed -$170K – 2904
2022
Q2 		$170K Hold
21,408
– – ﹤0.01% 1894
2022
Q1 		$314K Hold
21,408
– – ﹤0.01% 1627
2021
Q4 		$432K Hold
21,408
– – ﹤0.01% 1557
2021
Q3 		$581K Hold
21,408
– – ﹤0.01% 1207
2021
Q2 		$521K Hold
21,408
– – ﹤0.01% 1209
2021
Q1 		$523K Hold
21,408
– – ﹤0.01% 1203
2020
Q4 		$685K Buy
+21,408
New +$702K ﹤0.01% 1110

Other funds holding ADCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCG
Vantage Consulting Group Virginia Beach, Virginia $19.7M AUM 280.87% 1-Year Est. Return
GGH
GCM Grosvenor Holdings Chicago, Illinois $901M AUM 28.6% 1-Year Est. Return

Zurich Cantonal Bank's ADCT Position: Q3 2022 in Review

Zurich Cantonal Bank sold out of ADC Therapeutics (ADCT) in Q3 2022, closing a stake of 21,408 shares — an estimated $170K sold.

Zurich Cantonal Bank first reported a position in ADCT in Q4 2020 and held it in 7 quarters. The position peaked at $685K in Q4 2020. 66 funds tracked by Wall St. Rank hold ADCT as of Q3 2022.

  • Zurich Cantonal Bank reported no remaining ADC Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 21,408 ADC Therapeutics shares in Q3 2022, an estimated $170K.
  • Zurich Cantonal Bank first reported a position in ADC Therapeutics in Q4 2020 and held it in 7 quarters.
  • Zurich Cantonal Bank's ADC Therapeutics position peaked at $685K in Q4 2020.
  • 66 funds tracked by Wall St. Rank held ADC Therapeutics as of Q3 2022.

Based on Zurich Cantonal Bank's 13F filing for Q3 2022, filed 9 Nov 2022.